A.Y. Obalı, et al.
Bioorganic Chemistry 100 (2020) 103885
phenanthroline and 5-chloro-8-quinolinol. Their structures were well
characterized.
and 4-((4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenoxy)methyl)-
benzaldehyde (0.1 g, 0.23 mmol) were carried out in 30 mL methanol
medium under reflux for 72 h. The reaction was monitored by TLC by
2
. Experimental section
using methanol/NH (4: 1) as the eluent. The crude dark yellow residue
3
was collected by filtration and washed with methanol and dried under
−
1
2.1. Materials and instrumentation
vacuum (yield %86). M.P. > 300 °C (decomp.). FT-IR υ(cm ): 3393
(
OH), 3055 (NH), 2870 (CH), 1683 (C]N), 1611 (C]O), 1248
1
The reagents and chemicals were purchased from Merck and Sigma-
(CeOeC). H NMR (DMSO‑d
6
) δ(ppm): 13.80 (b, s, 1H, NH), 13.12 (b,
Aldrich and used without further purification. Melting points were
s, 2H, OH), 8.92 (s, 1H, HC = N), 9.1–7.3 (m, 17H, aromatic-CH), 5.45
1
13
13
determined by Büchi Melting Point B-540 instrument. H NMR and
C
(s, 2H, O-CH
2
). C NMR (DMSO‑d
6
): δ (ppm) = 168, 167, 161, 160,
NMR spectra were recorded on a Varian 400-MHz Spectrometer and
Bruker Biospin 300-MHz Spectrometer, respectively. Infrared spectra
were measured using a Bruker Fourier Transform-Infrared (FT-IR)
Spectrometer. Elemental analyses were carried out using a LECO-CHNS-
153, 152, 151, 149, 148, 145, 136, 134, 133, 131, 130, 129, 127, 124,
119, 118, 116, 69. Elemental analysis (C35
H
23
N
5
5
O ), Calculated
(Found) %: C: 70.82 (70.74), H: 3.91 (3.89), N: 11.80 (11.73).
2-(4-(((5-chloroquinolin-8-yl)oxy)methyl)phenyl)-1H-imidazo[4,5-
f][1,10]phenanthroline, 3. 5-Chloro-8-quinolinol (0.046 g, 0.25 mmol)
was dissolved in 30 mL methanol and then added dropwise to the me-
thanol solution of 2-(4-(bromomethyl)phenyl)-1H-imidazo[4,5-f][1,10]-
phenanthroline (0.1 g, 0.25 mmol) and triethylamine (0.034 mL,
0.25 mmol). The mixture was refluxed for 48 h. The reaction was mon-
9
32 elemental analyzer. High-Resolution Mass Spectroscopy was re-
corded on Waters SYNAPT G1 MS at positive mode (ES + )50–1000 Da.
UV–vis spectra were recorded on Perkin Elmer Lambda 25 UV–Vis
Spectrometer. Fluorescence data were obtained by using a Perkin Elmer
LS 55 Luminescence Spectrometer. All measurements were carried out
at 298 K. Thin layer chromatography (TLC) plates were supplied from
merck (silica gel 60 F254 on aluminum.
itored by TLC by using methanol/NH (4: 1) as the eluent. After the re-
3
action completed, evaporation of the solvents were performed. Light
yellow solid residue was washed with water. Then dried under vacuum.
−1
2.2. Synthesis procedures
(yield %90). M.P. > 300 °C (decomp.). FT-IR υ(cm ): 3151 (NH), 2921
1
(
CH), 1651 (C]N), 1279 (CeOeC), 550 (C-Cl). H NMR (DMSO‑d
6
)
1
,10-Phenantroline-5,6-dione, 4-(1H-imidazo[4,5–f][1,10]phenan-
δ(ppm): 13.66 (b, s, 1H, NH), 9.2–7.3 (m, 15H, aromatic-CH), 4.85 (s, 2H,
13
throline-2-yl)phenol (1), 2-(4-(bromomethyl)phenyl)-1H-imidazo[4,5-f]
O-CH
2
). C NMR (DMSO‑d ): δ (ppm) = 157, 153, 152, 150, 148, 145,
6
[
1,10]phenanthroline, 4-((4-(1H-imidazo-[4, 5-f][1,10]phenanthrolin-2-
142, 135, 134, 133, 129, 128, 127, 124, 123, 118, 116, 115, 107, 71.
yl)-phenoxy)methyl)benzaldehyde were synthesized via the literature
Elemental analysis (C29
H18ClN
5
O), Calculated (Found) %: C: 71.38
+
methods [33,34].
(71.34), H: 3.72 (3.64), N: 14.35 (14.28). HRMS (ESI) (m/z) (M + H) :
1
,10-Phenantroline-5,6-dione. 1,10-Phenanthroline (0.54 g, 3 mmol)
488.12.
was added into a solution of 60% sulfuric acid (7 mL). After the solid
compound was dissolved, potassium bromate (0.55 g, 3.3 mmol) was
added in batches over a period of half an hour. The mixture was stirred at
room temperature for 20 h. Then, the mixture was poured over ice and
was carefully neutralized to pH:7 using a saturated solution of sodium
hydroxide. The solution was then filtered, extracted with di-
chloromethane and evaporated to dryness. The crude product was re-
crystallized from methanol to provide the desired product.
2.3. Antimicrobial activities
In antimicrobial activity studies, the minimum inhibitory con-
centration values of compounds were determined by using broth mi-
crodilution method. Antibacterial activity of compound individually
tested against different microorganisms [Bacillus subtilis ATCC
6633(G + ), Pseudomonas aeruginosa ATCC 29853(G-), Escherichia coli
ATCC 35,218 (G-), Enterococcus faecalis ATCC 292,112 (G + ),
Salmonella typhimurium ST-10 (G-), Streptococcus mutans NCTC 10,449
(G + ), and Staphylococcus aureus ATCC 25923(G + )]. Gram positive
and gram negative bacteria were grown on Mueller-Hinton agar plates
and incubated at 37 °C for 24 h.
4
-(1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)phenol, 1. 1,10-
Phenanthroline-5,6-dione (0.1 g, 0.46 mmol) and ammonium acetate
0.58 g, 13.3 mmol) were dissolved in 10 mL of hot glacial acetic acid.
While the mixture was stirred, a solution of 4-hydroxybenzaldehyde
(
(
0.056 g, 0.46 mmol) in 10 mL of glacial acetic acid was added drop-
wise to the mixture. The mixture was heated at 90 °C for 3 h and was
then poured in 200 mL of water. The solution was neutralized with
ammonia to pH:7 and was then cooled to room temperature. The pre-
cipitate was filtered off and washed with large portions of water. The
product was dried for 48 h in a vacuum at 50 °C.
MIC value was determined by using microplate. The bacterial sus-
8
pensions were adjusted to 0.5 McFarland standard turbidity (10 CFU/
5
ml). Finally, these suspensions used as inoculums were prepared at 10
CFU/ml by diluting fresh cultures at McFarland 0.5 density. Mueller-
Hinton Broth (100 µl) was placed into each 96 wells of microplates.
Compound solutions initially prepared at a concentration of 10000 µM
were added into first wells of microplates and two fold dilutions of the
compounds (2500–2,44 µM) were made by dispensing the solutions to
the remaining wells. Then, 100 µl of culture suspensions were in-
oculated to each well. Chloramphenicol (2500–2,44 µM) was used as
control. The sealed microplates were incubated at 37 °C for 24 h.
Microbial growth was determined by adding 200 µl of 2,3,5-Triphenyl-
tetrazolium chloride (0.5%) after incubation to each well and in-
cubating for 30 min at 37 °C. The lowest concentration of the com-
pounds that completely inhibit macroscopic growth was determined as
minimum inhibitory concentrations (MICs).
2-(4-(bromomethyl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthro-
line. A mixture of 1,10-phenanthroline-5,6-dione (0.25 g, 1.2 mmol),
ammonium acetate (2.6 g, 1.2 mmol), 4-(bromomethyl)benzaldehyde
(
0.25 g, 0.46 mmol) and 30 mL glacial acetic acid were refluxed for
4
8 h and then poured in 200 mL of water. The solution was neutralized
with ammonia to pH:7 and cooled to room temperature. The precipitate
was collected and washed with water. The crude yellow product was
dried under vacuum.
4-((4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)-phenoxy)me-
thyl)benzaldehyde. To the solution of 4-(bromomethyl)benzaldehyde in
mL DMF, 4-(1H-imidazo[4,5-f][1,10] phenanthroline-2-yl)phenol
3
0
(
0.15 g, 0.5 mmol) and K
2
CO (0.13 g, 1 mmol) were added. The
3
mixture was stirred for 36 h at 90 °C. Then cooled to room temperature
and 50 mL water as added to the solution. The resulting crude product
were filtered and washed with cold water.
2.4. DNA cleavage activity
The interactions of the compounds with supercoiled pBR322
plasmid DNA were studied by agarose gel electrophoresis. The com-
plexes were incubated with pBR322 DNA in the dark at 37 °C for 24 h
and electrophoresed in 1% agarose gel electrophoresis. The gel was
(
E)-5-((4-((4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phe-
noxy)methyl)benzylidene) amino)isophthalic acid, 2. Schiff base
condensation reaction of 5-aminoisophthalic acid (0.04 g, 0.23 mmol)
2